Combined Genetic and Chemical Capsid Modifications Enable Flexible and Efficient De- and Retargeting of Adenovirus Vectors
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (1) , 107-117
- https://doi.org/10.1016/j.ymthe.2005.03.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vectorMolecular Therapy, 2004
- Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purificationMolecular Therapy, 2003
- Antibody-Mediated Targeting of an Adenovirus Vector Modified To Contain a Synthetic Immunoglobulin G-Binding Domain in the CapsidJournal of Virology, 2003
- Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface ReceptorsJournal of Virology, 2002
- Targeting of High-Capacity Adenoviral VectorsHuman Gene Therapy, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Targeting of adenoviral vectors through a bispecific single-chain antibodyCancer Gene Therapy, 2000
- Erratum: Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2Nature Medicine, 1999
- Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2 antibodyNature Biotechnology, 1999
- Development of Novel Cell Surface CD34-Targeted Recombinant Adenoassociated Virus Vectors for Gene TherapyHuman Gene Therapy, 1998